This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated LAMP2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-LAMP2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~45 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Cerebellum (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 3 isoform(s) |
The A01573 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HepG2 cell lysate (catalog A01573) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A01573 · (A) 1 and (B) 2 μg/mL (catalog A01573) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
UniProt predicts a 45 kDa LAMP2 precursor; glycosylation, signal-peptide removal, isoforms and oligomers may affect bands, but no empirical migration is supplied.
| Band near 45 kDa | Consistent with the predicted precursor mass; identity needs confirmation. |
| Band above 45 kDa | May reflect N-linked glycosylation; its migration is not established. |
| Band below 45 kDa | May reflect removal of the signal peptide at residues 1–28. |
| Additional bands at different positions | Could reflect LAMP-2A, LAMP-2B and LAMP-2C; distinct migration is not established. |
| Band near twice the monomer position | Could reflect a homodimer if it persists during electrophoresis. |
| UniProt predicted precursor mass | Sets a 45 kDa sequence-based reference, not a validated migration position. |
| N-linked glycosylation at Asn-32 and Asn-38 | May raise apparent mass; both sites carry polylactosaminoglycan annotations. |
| Signal peptide at residues 1–28 | Its removal makes the mature chain smaller than the precursor. |
| LAMP-2A, LAMP-2B and LAMP-2C isoforms | May differ in size; their individual masses and migration are not supplied. |
| Homodimer formation | May yield a band near twice the monomer position if the complex survives electrophoresis. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | LAMP2 is a lysosome and endosome membrane protein that may be poorly recovered. | Check membrane protein extraction and compare a membrane-enriched fraction. |
| Band higher than expected | N-linked glycans or persistent homooligomers may increase apparent size. | Compare reducing conditions and assess glycosylation with appropriate controls. |
| Band lower than expected | Removal of the residues 1–28 signal peptide reduces chain size. | Check antibody epitope coverage and confirm band identity with an independent antibody. |
| Broad smear instead of sharp band | Heterogeneous N-linked glycosylation is possible across the annotated sites. | Compare glycosidase-treated and untreated samples with a loading control. |
| Multiple bands | The three named isoforms or persistent oligomers may contribute, but distinct bands are unproven. | Compare reducing conditions and validate bands with an independent antibody. |
| Weak or no signal | Extraction may recover little membrane-associated LAMP2. | Check transfer and loading, then compare membrane-enriched lysate. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | Bergmann glia - cytoplasm/membrane | High | Protein (IHC) | HPA → |
| Epididymis | glandular cells | High | Protein (IHC) | HPA → |
| Gallbladder | glandular cells | High | Protein (IHC) | HPA → |
| Kidney | proximal tubules (cell body) | High | Protein (IHC) | HPA → |
| Placenta | trophoblastic cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Heart muscle | cardiomyocytes | Low | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Low | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Low | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for LAMP2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-LAMP2 antibodies have WB images: A01573 in HepG2 lysate, M01573 in JAR lysate, and A01573-3 in six human cell lysates. No publication evidence is supplied. A01573-3 reports a 100–110 kDa band versus an expected 45 kDa.
Which to pick: Choose by listed reactivity: A01573 covers human and mouse, M01573 covers human, mouse and rat, and A01573-3 covers human. All have WB images. For human samples, A01573-3 provides detailed conditions, but note its reported band-size discrepancy.